PCG
AZN icon

Prosperity Consulting Group’s AstraZeneca AZN Stock Holding History

Prosperity Consulting Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$903K Buy
4,762
+2,088
+78% +$393K 0.03% 284
2026
Q1 		$527K Buy
2,674
+714
+36% +$138K 0.02% 351
2025
Q4 		$360K Buy
1,960
+371
+23% +$65.1K 0.02% 409
2025
Q3 		$244K Buy
+1,589
New +$240K 0.01% 454

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Prosperity Consulting Group's AZN Position: Q2 2026 in Review

Prosperity Consulting Group increased its AstraZeneca (AZN) stake by 78% in Q2 2026, buying an estimated $393K and bringing the position to 4,762 shares worth $903K. The position accounts for 0.03% of the portfolio, ranked #284.

Prosperity Consulting Group first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Prosperity Consulting Group held 4,762 shares of AstraZeneca worth $903K as of Q2 2026.
  • Prosperity Consulting Group bought 2,088 AstraZeneca shares in Q2 2026, an estimated $393K.
  • AstraZeneca made up 0.03% of Prosperity Consulting Group's portfolio in Q2 2026, its #284 holding.
  • Prosperity Consulting Group first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.